Gestational Diabetes — Setting Limits, Exploring Treatments
Authors:
- Jeffrey L. EckerJEJeffrey L. Ecker
- Michael F. GreeneMGMichael F. Greene
- 8 May 2008
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 358 (19) , 2061-2063
Abstract
Pregnancy is associated with relative carbohydrate intolerance and insulin resistance. Gestational diabetes mellitus (carbohydrate intolerance first diagnosed during pregnancy) has long been recognized as a risk factor for a number of adverse outcomes during pregnancy, including excessive fetal growth, an increased incidence of birth trauma and cesarean delivery, and neonatal metabolic abnormalities such as polycythemia, hyperbilirubinemia, and hypoglycemia.1 This recognition has led to recommendations to screen all pregnant women for gestational diabetes mellitus and to treat those whose glucose-tolerance tests exceed threshold criteria.2 The threshold criteria for diagnosing gestational diabetes were initially specified rather arbitrarily as values greater than 2 . . .Keywords
This publication has 6 references indexed in Scilit:
- Hyperglycemia and Adverse Pregnancy OutcomesNew England Journal of Medicine, 2008
- Metformin versus Insulin for the Treatment of Gestational DiabetesNew England Journal of Medicine, 2008
- Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy OutcomesNew England Journal of Medicine, 2005
- Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task ForceObstetrics & Gynecology, 2003
- A Comparison of Glyburide and Insulin in Women with Gestational Diabetes MellitusNew England Journal of Medicine, 2000
- Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetesAmerican Journal of Obstetrics and Gynecology, 1995